Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab study in hepatocellular carcinoma is available, showing its study design, eligibility criteria, treatment plan, and outcome measures instead of a 403 error.
    Difference
    45%
    Check dated 2026-11-08T14:35:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision in the footer changed from v3.7.2 to v3.8.0, while the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:49:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:25:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T16:13:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov 403 error page footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T16:32:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the study record content that previously described the NCT03337841 trial. This signals restricted access to the study information on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-20T22:28:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.